A model for ZNF217-driven deleterious functions in ER+ breast cancer cells involving interference with and enhancement of ERα signaling and its related mitogenic downstream events, at least via the direct genomic activity of ERα, is proposed (Figure 3). The gene discussed is ESR1; the disease is breast carcinoma.